Biotage entrusts PartnerTech with greater responsibility - Instrument manufacture

Biotage entrusts PartnerTech with greater responsibility - Instrument
manufacture 

PartnerTech and Biotage, an international company in the field of life science
research, have long cooperated on a far-reaching basis. Now the two companies
are expanding their collaboration through a new agreement according to which
PartnerTech will take over most instrument manufacture, currently located at
Biotage's plant in Charlottesville, Virginia. Running initially through 2011,
the agreement is worth approximately SEK 40 million annually. 

“After many years of close cooperation, we know that PartnerTech has the
experience and organization required to handle an assignment of this magnitude,”
says Torben Jörgensen, President and CEO of Biotage. “We are very pleased with
PartnerTech's production capacity and rapid response time. We have also
benefited greatly from PartnerTech's product development division, which has
made our instruments more competitive.” 

Biotage has long collaborated with PartnerTech on the development and production
of its instruments. The new agreement involves the relocation of instrument
manufacture from the Biotage plant in Charlottesville, Virginia to the
PartnerTech customer center in Åtvidaberg, Sweden. After the relocation,
PartnerTech will manufacture nearly all Biotage instruments. The product
transfer will begin immediately. Initial deliveries will be made in June, and
the transfer is scheduled for completion in the third quarter. 
 
“We are very happy that Biotage is entrusting more of its production to us,”
says Rune Glavare, President and CEO of PartnerTech. “It reaffirms that
PartnerTech has a strong offering and the kind of expertise needed to support
product development and the manufacture of medical devices. Our industrial
structure, global supply chain and refined manufacturing expertise ensure that
our customers have efficient, cost-effective and flexible production.”

For additional information, please call: 
Rune Glavare, President and CEO, PartnerTech AB, +46 (0) 706 20 24 54
Torben Jörgensen, President and CEO, Biotage AB, +46 (0)707-49 05 84


Biotage
As an international company in the field of life science research, Biotage AB
has advanced technologies, wide-ranging operations and a long-term view of the
market. The company provides solutions, expertise and experience in medicinal
chemistry. In 2005, Biotage acquired operations and products from Argonaut,
further strengthening its product portfolio in medicinal chemistry. Among its
customers are the 30 biggest pharmaceutical companies and the 20 biggest biotech
companies in the world, as well as leading academic institutions. Headquartered
in Uppsala, Sweden, the company has subsidiaries in the United States, Japan,
the UK, Germany and several other European countries. Biotage (www.biotage.com)
has some 300 employees, reported sales of SEK 385.3 million in 2008 and is
listed on the NASDAQ OMX Nordic Exchange Stockholm. 

PartnerTech
PartnerTech develops and manufactures products under contract for leading
companies, primarily in Defense and Maritime, Industry, Information Technology,
MedTech & Instrumentation, CleanTech and Point of Sale Applications. With some
1,500 employees at its plants in Sweden, Norway, Finland, Poland, the UK, the
United States and China, PartnerTech reports annual sales of approximately SEK
2.5 billion. PartnerTech AB (www.partnertech.com), the parent company, is
headquartered in Malmö, Sweden and listed on the NASDAQ OMX Nordic Exchange
Stockholm. www.partnertech.se

The disclosures have been sent to the Swedish Financial Supervisory Authority
(Finansinspektionen).